|82.06|| +0.25 / +0.31%|
Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
|Vasant Narasimhan||Chief Executive Officer|
|Harry Kirsch||Chief Financial Officer|
|Shannon Thyme Klinger||Head-Litigation, Chief Ethics & Compliance Officer|
|Mimi Huizinga||VP & Head-Strategic Data|
|Stephen Moran||Global Head-Strategy|